Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
US-2026078199-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Takeda Pharmaceuticals Co — Physics
Takeda Pharmaceuticals Co holds 115 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Takeda Pharmaceuticals Co |
| Technology | Physics |
| Patents in slice | 115 |
| Recent patents in slice | 72 |
| First year | 2019 |
| Last year | 2026 |
Representative patents
Notable publications linking Takeda Pharmaceuticals Co to Physics.
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
US-2026078199-A1 · Mar 19, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Recent filings
Latest patents from Takeda Pharmaceuticals Co in Physics.
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
US-2026078199-A1 · Mar 19, 2026 · US
Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies
US-2026078199-A1 · Mar 19, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Determination of modification degree of therapeutic proteins using 1H-NMR spectroscopy
US-12553842-B2 · Feb 17, 2026 · US
Related pages
Navigate to parent entity pages.